Ultimate Medicine AG, a Swiss preclinical pharmaceutical company, is developing an innovative oral treatment for age-related cognitive disorders. Our approach targets an overlooked pathway complementing standard amyloid-β/tau therapies.
Products, services, technology
Ultimate Medicine AG develops innovative oral therapies for Alzheimer’s and age-related cognitive decline. Our small molecule targets a novel disease pathway, addressing multiple impairment mechanisms with integrated biomarkers for patient selection and monitoring.
- https://www.ultimatemedicine.com
- Send an email
- Antal Szalay, CEO & Founder